Pacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million

MT Newswires Live05-22

Cancer diagnostics company Pacific Edge (NZE:PEB, ASX:PEB) said operating revenue rose 22% to NZ$23.9 million and total revenue increased 12% to NZ$29.3 million for the year ended March, according to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2437147953?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-05-22 05:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2437147953","market":"fut","top_or_hot":-1,"title":"Pacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million","media":"MT Newswires Live","content":"<div>\n<p>Cancer diagnostics company Pacific Edge (NZE:PEB, ASX:PEB) said operating revenue rose 22% to NZ$23.9 million and total revenue increased 12% to NZ$29.3 million for the year ended March, according to ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge FY2024 Operating Revenue Jumps 22% to NZ$23.9 Million, Total Revenue Rises 12% to NZ$29.3 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-22 05:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cancer diagnostics company Pacific Edge (NZE:PEB, ASX:PEB) said operating revenue rose 22% to NZ$23.9 million and total revenue increased 12% to NZ$29.3 million for the year ended March, according to ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AUD","symbol_name":"Audacy Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2437147953","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2437147953","pubTimestamp":1716327863,"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Cancer diagnostics company Pacific Edge (NZE:PEB, ASX:PEB) said operating revenue rose 22% to NZ$23.","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AUD":"Audacy Inc.","NZ20C.NZ":"S&P/NZX 20","BK7067":"生物科技","BK4181":"酒店及度假村房地产投资信托","NZ50G.NZ":"S&P/NZX 50","BK4125":"广播","T10G.NZ":"S&P/NZX 10","BK4218":"酒店及度假村房地产信托","PEB.AU":"PACIFIC EDGE LTD","PEB":"Pebblebrook Hotel Trust"},"translate_title":"Pacific Edge 2024财年营业收入跃升22%至2390万新西兰元，总收入增长12%至2930万新西兰元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUD":1,"NZ20C.NZ":1,"NZ50G.NZ":1,"PEB":1,"PEB.AU":1,"T10G.NZ":1},"content_text":"Cancer diagnostics company Pacific Edge (NZE:PEB, ASX:PEB) said operating revenue rose 22% to NZ$23.9 million and total revenue increased 12% to NZ$29.3 million for the year ended March, according to a Tuesday New Zealand bourse filing.The company's average US sales price increased 18% to $613 in H2 2024 on cash collection improvements and increased volumes from Kaiser Permanente, the filing said. Cash burn fell 24% to NZ$11.9 million in H2 2024 compared with H1 after a reorganization, according to the filing.Pacific Edge has refocused its business on the clinical development of its Detect and Monitor tests, which is delivering on its goals, the filing said.Price (AUD): $0.10, Change: $-0.01, Percent Change: -6.86%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2437147953"}